Bain Capital Life Sciences Fund, L.P. 13D and 13G filings for X4 Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-13 9:40 pm Purchase | 2025-08-11 | 13D | X4 Pharmaceuticals, Inc. XFOR | Bain Capital Life Sciences Fund, L.P. | 2,436,526 9.990% | 2,436,526 (New Position) | Filing |